On February 5, 2026, Moleculin Biotech, Inc. held a special meeting where shareholders approved issuing up to 2,610,823 shares from warrants, but did not approve a name change to Moleculin Inc. The meeting had 1,196,312 shares represented, ensuring a quorum.